Information  X 
Enter a valid email address

Anglo American PLC (AAL)

  Print      Mail a friend       Annual reports

Friday 11 October, 2019

Anglo American PLC

Director/PDMR Shareholding

RNS Number : 6744P
Anglo American PLC
11 October 2019
 

Anglo American plc ("the Company")

Registered office: 20 Carlton House Terrace, London SW1Y 5AN

Registered number: 3564138 (incorporated in England and Wales)

LEI: 549300S9XF92D1X8ME43

 

Notification of a transaction by a PDMR

The Company was notified on 11 October 2019 of a purchase of its Ordinary Shares by a PDMR in respect of the reinvestment of the 2019 Interim Dividend.

In accordance with Article 19 of the EU Market Abuse Regulation, the relevant FCA notifications are set out below.

 

1.

Details of PDMR / PCA

a)

Name

Themba Mkhwanazi

2.

Reason for the notification

a)

Position / status

CEO of Kumba Iron Ore (PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

 

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

 

 

GB00B1XZS820

b)

Nature of the transaction

Reinvestment of 2019 Interim Dividend

c)

Currency

ZAR - South African Rand

d)

Price(s) and volume(s)

Price(s)

Volume(s)

ZAR 346.30

477

e)

Aggregated information

 

Aggregated volume

 

Price

 

 

477

 

ZAR 346.30

f)

Date of the transaction

2019-10-09

g)

Place of the transaction

Johannesburg Stock Exchange - XJSE

 

 

Clare Davage

Deputy Company Secretary

11 October 2019

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFEVIELLLIA

a d v e r t i s e m e n t